Skip to main content

Table 3 Rates of detected germline MLH1 and MSH2 mutations in Chinese typical and suspected HNPCC patients

From: Hereditary Colorectal Cancer in China

Clinical Criteria

positive/screened

percentage

reference

Amsterdam

23/52

44%

[18–20, 22, 23]

Japan

8/24

33%

[19, 20, 22]

Korea/China

5/23

22%

[18]*

Bethesda

1/19

5%

[22]

  1. * partly based on unpublished data